Native New Zealand plants with inhibitory activity towards Mycobacterium tuberculosis

BMC Complementary and Alternative Medicine

Volumn 10, Issue , 2010, Pages

  Earl, Emma A ^a   Altaf, Mudassar ^a   Murikoli, Rekha V ^a   Swift, Simon ^b   O'Toole, Ronan ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LAURELIA NOVAE ZELANDIAE PLANT EXTRACT; LOPHOMYRTUS BULLATA PLANT EXTRACT; METROSIDEROS EXCELSA PLANT EXTRACT; MYOPORUM LAETUM PLANT EXTRACT; PITTOSPORUM TENUIFOLIUM PLANT EXTRACT; PLANT EXTRACT; PSEUDOPANAX CRASSIFOLIUS PLANT EXTRACT; SOLVENT; UNCLASSIFIED DRUG; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; BARK; CONTROLLED STUDY; FLOWER; LAURELIA NOVAE ZELANDIAE; MEDICINAL PLANT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NEW ZEALAND; NONHUMAN; PLANT LEAF; STAPHYLOCOCCUS AUREUS; ANGIOSPERM; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM; TUBERCULOSIS;

ANGIOSPERMS; ANTITUBERCULAR AGENTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NEW ZEALAND; PLANT EXTRACTS; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS;

EID: 77953258983     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-10-25     Document Type: Article

References (34)

1. National Institute of Allergy and Infectious Diseases NIoH Understanding Microbes in Sickness and in Health. 2006, National Institute of Allergy and Infectious Diseases NIoH., http://www3.niaid.nih.gov/topics/microbes/PDF/microbesbook.pdf
2. WHO World Health Organization Report 2009, Global tuberculosis control: epidemiology, strategy, financing. 2009, World Health Organization, WHO., http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pd f
3. Wade MM, Zhang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Frontiers in Bioscience 2004, 9:975-994. 10.2741/1289, 14766424.
4. WHO World Health Organisation and the Stop TB Partnership. Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. 2006, WHO.
5. IUATLD Anti-tuberculosis drug resistance in the world, report no. 4. 2008, International Union Against Tuberculosis and Lung Disease, IUATLD., http://www.who.int/tb/features_archive/drsreport_launch_26feb08/en/index .html
6. CDC Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. Morbidity and Mortality Weekly Report 2006, 55:301-305. CDC.
7. WHO Countries that had reported at least one XDR-TB case by September 2009. 2009, WHO., http://www.who.int/tb/challenges/xdr/xdr_map_sep09.pdf
8. WHO Global Plan to Stop TB. World Health Organisation and the Stop TB Partnership 2006, WHO.
9. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. Journal of Infectious Diseases 2002, 185(8):1197-1202. 10.1086/339818, 11930334.
10. Rojas R, Caviedes L, Aponte JC, Vaisberg AJ, Lewis WH, Lamas G, Sarasara C, Gilman RH, Hammond GB. Aegicerin, the First Oleanane Triterpene with Wide-Ranging Antimycobacterial Activity, Isolated from Clavija procera. Journal of Natural Products 2006, 69(5):845-846. 10.1021/np050554l, 16724857.
11. Limsuwan S, Trip EN, Kouwen TRHM, Piersma S, Hiranrat A, Mahabusarakam W, Voravuthikunchai SP, van Dijl JM, Kayser O. Rhodomyrtone: A new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 2009, 16(6-7):645-651. 10.1016/j.phymed.2009.01.010, 19303274.
12. Miller CH, Nisa S, Dempsey S, Jack C, O'Toole R. Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria. Antimicrobial Agents and Chemotherapy 2009, 53(12):5279-5283. 10.1128/AAC.00803-09, 2786345, 19786608.
13. Perehinec TM, Qazi SN, Gaddipati SR, Salisbury V, Rees CE, Hill PJ. Construction and evaluation of multisite recombinatorial (Gateway) cloning vectors for Gram-positive bacteria. BMC Molecular Biology 2007, 8:80. 10.1186/1471-2199-8-80, 2039747, 17880697.
14. Kraemer GR, Iandolo JJ. High-frequency transformation of Staphylococcus aureus by electroporation. Current Microbiology 1990, 21(6):373-376.
15. Novick RP. Genetic systems in Staphylococci. Methods in Enzymology 1991, 204:587-636. full_text, 1658572.
16. O'Toole R, Von Hofsten J, Rosqvist R, Olsson PE, Wolf-Watz H. Visualisation of zebrafish infection by GFP-labelled Vibrio anguillarum. Microbial Pathogenesis 2004, 37(1):41-46. 10.1016/j.micpath.2004.03.001, 15194159.
17. Tabuti JRS, Kukunda CB, Waako PJ. Medicinal plants used by traditional medicine practitioners in the treatment of tuberculosis and related ailments in Uganda. Journal of ethnopharmacology 2010, 127:130-136. 10.1016/j.jep.2009.09.035, 19799983.
18. Eldeen IMS, van Staden J. Antimycobacterial activity of some trees used in South African traditional medicine. South African Journal of Botany 2007, 73:248-251.
19. Camacho-Corona Mdel R, Ramirez-Cabrera MA, Santiago OG, Garza-Gonzalez E, Palacios Ide P, Luna-Herrera J. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases. Phytotherapy Research 2008, 22(1):82-85. 10.1002/ptr.2269, 17726732.
20. Larsen L, Benn MH, Parvez M, Perry NB. A cytotoxic triketone-phloroglucinol-bullatenone hybrid from Lophomyrtus bullata. The Royal Society of Chemistry 2005, 3:3236-3241.
21. Newton SM, Lau C, Wright CW. A review of antimycobacterial natural products. Phytotherapy Research 2000, 14(5):303-322. 10.1002/1099-1573(200008)14:5<303::AID-PTR712>3.0.CO;2-N, 10925394.
22. Brooker SG, Cambie RC, Cooper RC. New Zealand Medicinal Plants. 1987, Auckland Reed Publishing (NZ) Ltd;, 2.
23. Goldie WH. Maori Medical Lore. 1998, Transactions of the New Zealand Institute. Auckland Southern Reprints;.
24. Clarke A. Botanist's records of medicinal plants uses. The great sacred forest of Tane 2007, 322. Auckland. Reed Publishing.
25. Wassilieff M. Tall broadleaf trees - Forest giants. Te Ara - the Encyclopedia of New Zealand 2009,
26. Dajas-Bailador FA, Asencio M, Bonilla C, Scorza MC, Echeverry C, Reyes-Parada M, Silveira R, Protais P, Russell G, Cassels BK, et al. Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission. General Pharmacology 1999, 32(3):373-379. 10.1016/S0306-3623(98)00210-9, 10211594.
27. Valiente M, D'Ocon P, Noguera MA, Cassels BK, Lugnier C, Ivorra MD. Vascular activity of (-)-anonaine, (-)-roemerine and (-)-pukateine, three natural 6a(R)-1,2-methylenedioxyaporphines with different affinities for alpha1-adrenoceptor subtypes. Planta Medica 2004, 70(7):603-609. 10.1055/s-2004-827181, 15254852.
28. Brooker SG, Cambie RC, Cooper RC. New Zealand Medicinal Plants. 1981, Auckland Heinemann publishers.
29. Taylor R. A leaf from the natural history of New Zealand. 1848,
30. Brooker SG, Cooper RC. New Zealand Medicinal Plants. Economic Botany 1962, 15(1):1-10.
31. Martin M. He Pukapuka Whakaata Tikanga Mo Nga Rongoa Mo Nga Kai. 1869, Auckland Henry Hill Publishers.
32. Macdonald C. Medicines of the maori. 1974, Auckland Collins.
33. Riley M. Maori Healing and Herbal: New Zealand Ethnobotanical Sourcebook. 1994, Paraparaumu Viking Sevenseas N.Z. Ltd.
34. Parsons C. Healing practices of the south pacific. 1985, University of Hawaii press.